iBio, Inc. (IBIO)

NASDAQ: IBIO · USD

$0.80

+0.04 (+4.7%)· Recorded snapshot

Market cap	51.7M
Revenue (ttm)	100K
Net income (ttm)	-33M
EPS (ttm)	-$0.32
Shares out	64.3M
Volume	271,579
Beta	1.26

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 100K
Net income (ttm): -33M
EPS (ttm): -$0.32
Market cap: 51.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-65.7

P25 n/aP50 n/aP75 n/a

ROIC-35.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All IBIO indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001420720
Company name	iBio, Inc.
Country	United States
Country code	US
CUSIP number	451033708
Earnings date	2026-11-11
Earnings time	amc
Employees	23
Employees change	3
Employees growth	15%
Enterprise value	$-34.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	June
Founded	2008
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US4510337086
Last 10-K release date	2026-08-28
Last earnings date	2026-08-28
Last refreshed	2026-10-28
Last stock split date	2023-11-29
Last stock split type	Reverse
Market cap	$51.7M
Market cap category	Micro-Cap
Next earnings date	2026-11-11
Options	No
Price	$0.80
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	IBIO
U.S. state	California
Website	https://ibioinc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-39.54%
FCF / EV yield	67.41%
FCF yield	-47.08%
Forward P/S	3,031.74x
P/B ratio	0.5x
P/S ratio	505.39x
Price / tangible book value	0.6x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Operating margin	-30,138%
Pretax margin	-33,044%
Profit per employee	$-1.4M
Revenue per employee	$4,348
ROA	-30.8%
ROA (5Y)	-29.19%
ROCE	-34.5%
ROE	-65.7%
ROE (5Y)	-72%
ROIC	-35.42%
SBC / revenue	1,373%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	4
Gross profit growth	-75%
Gross profit growth 5Y	-35.69%
Net income growth years	0
Revenue growth	-75%
Revenue growth 10Y	-20.14%
Revenue growth 5Y	-46.91%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-578,000
Depreciation and amortization	$646,000
EBIT	$-30.1M
EBITDA	$-29.5M
EPS	$-0.32
FCF per share	$-0.37
Financing cash flow	$103M
Free cash flow	$-23.8M
Free cash flow minus SBC	$-25.2M
Gross profit	$100,000
Investing cash flow	$-32M
Net borrowing	$-774,000
Net cash flow	$47.8M
Net income	$-33M
Operating cash flow minus SBC	$-24.6M
Operating income	$-30.1M
Revenue	$100,000
Stock-based compensation	$1.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-3.07
Book value per share	$1.54
Debt / equity	0.03
Interest coverage	-568.64
Long-term assets	$6.9M
Long-term liabilities	$1.7M
Net cash (debt)	$85.8M
Net cash / market cap	169.85%
Net cash growth	1,613.39%
Net debt / equity	-1
Piotroski F-Score	2
Property, plant and equipment	$4.8M
Shareholders' equity	$85.7M
Tangible book value	$83.9M
Tangible book value per share	$1.51
Total assets	$99.1M
Total cash	$88M
Total debt	$2.2M
Total liabilities	$13.4M
WACC	10.78%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$92.2M
Current liabilities	$11.7M
Current ratio	7.85
Net working capital	$-7M
Quick ratio	7.5
Working capital	$80.5M
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-891.14%
Dividend yield	0%
Shareholder yield	-891.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.97%
10Y return CAGR	-55.42%
10Y total return	-99.97%
150-day SMA	$1.49
15Y price change	-99.99%
15Y return CAGR	-46.55%
15Y total return	-99.99%
1D price change	4.73%
1M price change	-33.46%
1M total return	-33.46%
1W price change	-3.56%
1W total return	-3.56%
1Y price change	-38.14%
1Y return CAGR	-38.16%
1Y total return	-38.14%
20-day SMA	$0.87
200-day SMA	$1.71
3M price change	-45.39%
3M total return	-45.39%
3Y price change	-86.37%
3Y return CAGR	-48.53%
3Y total return	-86.37%
50-day SMA	$1.12
50-day SMA vs 200-day SMA	50under200
52-week high	$3.82
52-week high date	2025-12-10
52-week low	$0.69
52-week low date	2026-10-26
5Y price change	-99.79%
5Y return CAGR	-70.92%
5Y total return	-99.79%
6M price change	-53.7%
6M total return	-53.7%
All-time high	$30,300.00
All-time high date	2011-01-18
All-time low	$0.56
All-time low date	2025-08-08
Average true range (ATR)	$0.08
Average volume	888.9K
Beta (1Y)	2.72
Beta (2Y)	1.06
Beta (5Y)	1.26
Change from 52-week high	-78.97%
Change from 52-week low	17.1%
Change from all-time high	-100%
Change from all-time low	42.36%
Change from open	4.43%
Day's gap	0.29%
Dollar volume	$218,132
High price	$0.80
Low price	$0.77
Monthly RSI	36.76
Open price	$0.77
Position in 52-week range	98.27%
Premarket change	0.4%
Premarket close	$0.77
Premarket price	$0.77
Premarket volume	5.3K
Previous close	$0.77
Price vs 150-day SMA	-46.86%
Price vs 20-day SMA	-9.04%
Price vs 200-day SMA	-53.7%
Price vs 50-day SMA	-29.49%
Relative volume	0.31
RSI	35.99
Sharpe ratio	0.01
Sharpe ratio (3Y)	0.13
Sharpe ratio (5Y)	-0.22
Sortino ratio	0.08
Sortino ratio (3Y)	0.31
Sortino ratio (5Y)	-0.36
Volume	271.6K
Weekly RSI	32.22
YTD price change	-58.97%
YTD total return	-58.97%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45.9M
Float percentage	71.32%
Shares change (QoQ)	21.53%
Shares change (YoY)	891.14%
Shares held by insiders	1.32%
Shares held by institutions	37.9%
Shares outstanding	64.3M
Short % of float	8.14%
Short % of shares	5.8%
Short ratio	6.9 days

Deeper analysis on IBIO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IBIO report

Is a complete IBIO research report available?

No complete published report is available for iBio, Inc. (IBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

iBio, Inc. (IBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · IBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IBIO

Frequently asked questions